Multistep Pathogenesis of Autoimmune Disease

Cell

Volumn 130, Issue 1, 2007, Pages 25-35

  Goodnow, Christopher C ^a  

^a Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BIM PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 7 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN A1; PROTEIN BCL 2; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CANALE SMITH SYNDROME; CANCER INHIBITION; CANCER SUSCEPTIBILITY; GENE MUTATION; GENE OVEREXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS C; HLA SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOMA; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMOCYTE; X CHROMOSOME;

EID: 34447098797     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2007.06.033     Document Type: Review

References (101)

1. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S., Turley S.J., Von Boehmer H., Bronson R., Dierich A., Benoist C., and Mathis D. Projection of an immunological self-shadow within the thymus by the aire protein. Science 298 (2002) 1395-1403
2. Araten D.J., Golde D.W., Zhang R.H., Thaler H.T., Gargiulo L., Notaro R., and Luzzatto L. A quantitative measurement of the human somatic mutation rate. Cancer Res. 65 (2005) 8111-8117
3. Araten D.J., Nafa K., Pakdeesuwan K., and Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc. Natl. Acad. Sci. USA 96 (1999) 5209-5214
4. Bende R.J., Aarts W.M., Riedl R.G., de Jong D., Pals S.T., and van Noesel C.J. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201 (2005) 1229-1241
5. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., and Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27 (2001) 20-21
6. Bernatsky S., Boivin J.F., Joseph L., Rajan R., Zoma A., Manzi S., Ginzler E., Urowitz M., Gladman D., Fortin P.R., et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 1481-1490
7. Bernatsky S., Lee J.L., and Rahme E. Non-Hodgkin's Lymphoma-Meta-Analyses of the eEffects of Corticosteroids and Non-Steroidal Anti-Inflammatories (2006), Rheumatology, Oxford
8. Betterle C., Greggio N.A., and Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab. 83 (1998) 1049-1055
9. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
10. L. Immunity 3 (1995) 87-98
11. Bretscher P., and Cohn M. A theory of self-nonself discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively. Science 169 (1970) 1042-1049
12. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
13. Buckler J.L., Walsh P.T., Porrett P.M., Choi Y., and Turka L.A. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J. Immunol. 177 (2006) 4262-4266
14. Burnet F.M. Autoimmunity and Autoimmune Disease (1972), Medical and Technical Publishing Co Ltd, Lancaster, UK
15. Cappione A., Anolik J.H., Pugh-Bernard A., Barnard J., Dutcher P., Silverman G., and Sanz I. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115 (2005) 3205-3216
16. Casola S., Otipoby K.L., Alimzhanov M., Humme S., Uyttersprot N., Kutok J.L., Carroll M.C., and Rajewsky K. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5 (2004) 317-327
17. Cellier C., Delabesse E., Helmer C., Patey N., Matuchansky C., Jabri B., Macintyre E., Cerf-Bensussan N., and Brousse N. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 356 (2000) 203-208
18. Chan O.T., Madaio M.P., and Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169 (1999) 107-121
19. Chapman C.J., Zhou J.X., Gregory C., Rickinson A.B., and Stevenson F.K. VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 88 (1996) 3562-3568
20. Chen C., Li H., Tian Q., Beardall M., Xu Y., Casanova N., and Weigert M. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J. Immunol. 176 (2006) 5183-5190
21. Cohen P.L., and Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9 (1991) 243-269
22. Corcos D., Grandien A., Vazquez A., Dunda O., Lores P., and Bucchini D. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells. J. Immunol. 166 (2001) 3083-3089
23. Di Cristofano A., Kotsi P., Peng Y.F., Cordon-Cardo C., Elkon K.B., and Pandolfi P.P. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285 (1999) 2122-2125
24. Egle A., Harris A.W., Bath M.L., O'Reilly L., and Cory S. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103 (2004) 2276-2283
25. Egle A., Harris A.W., Bouillet P., and Cory S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA 101 (2004) 6164-6169
26. Erickson R.P. Somatic gene mutation and human disease other than cancer. Mutat. Res. 543 (2003) 125-136
27. Fairhurst A.M., Wandstrat A.E., and Wakeland E.K. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv. Immunol. 92 (2006) 1-69
28. Fearnhead N.S., Wilding J.L., Winney B., Tonks S., Bartlett S., Bicknell D.C., Tomlinson I.P., Mortensen N.J., and Bodmer W.F. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc. Natl. Acad. Sci. USA 101 (2004) 15992-15997
29. Fearon D.T., and Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18 (2000) 393-422
30. Foy T.M., Aruffo A., Bajorath J., Buhlmann J.E., and Noelle R.J. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14 (1996) 591-617
31. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., and Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
32. Glynne R., Akkaraju S., Healy J.I., Rayner J., Goodnow C.C., and Mack D.H. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 403 (2000) 672-676
33. Goodnow C.C. Immunology. Discriminating microbe from self suffers a double toll. Science 312 (2006) 1606-1608
34. Goodnow C.C., Sprent J., de St Groth B.F., and Vinuesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435 (2005) 590-597
35. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
36. Gregersen P.K., Lee H.S., Batliwalla F., and Begovich A.B. PTPN22: setting thresholds for autoimmunity. Semin. Immunol. 18 (2006) 214-223
37. Gronbaek K., Straten P.T., Ralfkiaer E., Ahrenkiel V., Andersen M.K., Hansen N.E., Zeuthen J., Hou-Jensen K., and Guldberg P. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 92 (1998) 3018-3024
38. Grumont R.J., Strasser A., and Gerondakis S. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Mol. Cell 10 (2002) 1283-1294
39. Haag-Liautard C., Dorris M., Maside X., Macaskill S., Halligan D.L., Charlesworth B., and Keightley P.D. Direct estimation of per nucleotide and genomic deleterious mutation rates in Drosophila. Nature 445 (2007) 82-85
40. Heissmeyer V., Macian F., Im S.H., Varma R., Feske S., Venuprasad K., Gu H., Liu Y.C., Dustin M.L., and Rao A. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5 (2004) 255-265
41. Holzelova E., Vonarbourg C., Stolzenberg M.C., Arkwright P.D., Selz F., Prieur A.M., Blanche S., Bartunkova J., Vilmer E., Fischer A., et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N. Engl. J. Med. 351 (2004) 1409-1418
42. Hussell T., Isaacson P.G., Crabtree J.E., and Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J. Pathol. 178 (1996) 122-127
43. Ignatowicz L., Kappler J., and Marrack P. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84 (1996) 521-529
44. Jevnikar A.M., Grusby M.J., and Glimcher L.H. Prevention of nephritis in major histocompatibility complex Class II-deficient MRL-lpr mice. J. Exp. Med. 179 (1994) 1137-1143
45. Jiang W., Anderson M.S., Bronson R., Mathis D., and Benoist C. Modifier loci condition autoimmunity provoked by Aire deficiency. J. Exp. Med. 202 (2005) 805-815
46. Jones R.G., Elford A.R., Parsons M.J., Wu L., Krawczyk C.M., Yeh W.C., Hakem R., Rottapel R., Woodgett J.R., and Ohashi P.S. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J. Exp. Med. 196 (2002) 335-348
47. Kane L.P., Lin J., and Weiss A. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol. 23 (2002) 413-420
48. Kim J.M., Rasmussen J.P., and Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8 (2007) 191-197
49. Koh D.R., Ho A., Rahemtulla A., Fung-Leung W.P., Griesser H., and Mak T.W. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25 (1995) 2558-2562
50. Komori H., Furukawa H., Mori S., Ito M.R., Terada M., Zhang M.C., Ishii N., Sakuma N., Nose M., and Ono M. A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice. J. Immunol. 176 (2006) 395-400
51. Kovanen P.E., and Leonard W.J. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202 (2004) 67-83
52. Krammer P.H. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71 (1999) 163-210
53. Lafferty K.J., Prowse S.J., Simeoniovic C.J., and Warren H.S. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1 (1983) 143-173
54. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
55. Liston A., Lesage S., Wilson J., Peltonen L., and Goodnow C.C. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4 (2003) 350-354
56. Liston A., Lesage S., Gray D.H., O'Reilly L.A., Strasser A., Fahrer A.M., Boyd R.L., Wilson J., Baxter A.G., Gallo E.M., et al. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21 (2004) 817-830
57. Liston A., Lesage S., Gray D.H., Boyd R.L., and Goodnow C.C. Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol. Rev. 204 (2005) 87-101
58. Ma J., Xu J., Madaio M.P., Peng Q., Zhang J., Grewal I.S., Flavell R.A., and Craft J. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 157 (1996) 417-426
59. Maldonado M.A., Kakkanaiah V., MacDonald G.C., Chen F., Reap E.A., Balish E., Farkas W.R., Jennette J.C., Madaio M.P., Kotzin B.L., et al. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J. Immunol. 162 (1999) 6322-6330
60. Marie J.C., Liggitt D., and Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25 (2006) 441-454
61. Marsh D.J., Kum J.B., Lunetta K.L., Bennett M.J., Gorlin R.J., Ahmed S.F., Bodurtha J., Crowe C., Curtis M.A., Dasouki M., et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 8 (1999) 1461-1472
62. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6 (2006) 823-835
63. Merino R., Shibata T., De Kossodo S., and Izui S. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur. J. Immunol. 19 (1989) 2131-2137
64. Muschen M., Re D., Jungnickel B., Diehl V., Rajewsky K., and Kuppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192 (2000) 1833-1840
65. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
66. Narayan P., Holt B., Tosti R., and Kane L.P. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol. Cell. Biol. 26 (2006) 2327-2336
67. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., and Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312 (2006) 1669-1672
68. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am. J. Hum. Genet. 69 (2001) 124-137
69. Rathmell J.C., and Goodnow C.C. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 153 (1994) 2831-2842
70. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts A., Debatin K., Fischer A., and de Villartay J. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 (1995) 1347-1349
71. Rieux-Laucat F., Hivroz C., Lim A., Mateo V., Pellier I., Selz F., Fischer A., and Le Deist F. Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N. Engl. J. Med. 354 (2006) 1913-1921
72. Santulli-Marotto S., Qian Y., Ferguson S., and Clarke S.H. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response. J. Immunol. 166 (2001) 5292-5299
73. Schattner E.J., Friedman S.M., and Casali P. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis. Autoimmunity 35 (2002) 283-289
74. Shlomchik M., Mascelli M., Shan H., Radic M.Z., Pisetsky D., Marshak-Rothstein A., and Weigert M. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171 (1990) 265-297
75. Silberstein L.E., Jefferies L.C., Goldman J., Friedman D., Moore J.S., Nowell P.C., Roelcke D., Pruzanski W., Roudier J., and Silverman G.J. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 78 (1991) 2372-2386
76. Smedby K.E., Hjalgrim H., Askling J., Chang E.T., Gregersen H., Porwit-MacDonald A., Sundstrom C., Akerman M., Melbye M., Glimelius B., and Adami H.O. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J. Natl. Cancer Inst. 98 (2006) 51-60
77. Smith K., Seddon B., Purbhoo M.A., Zamoyska R., Fisher A.G., and Merkenschlager M. Sensory adaptation in naive peripheral CD4 T cells. J. Exp. Med. 194 (2001) 1253-1261
78. Soderberg K.C., Jonsson F., Winqvist O., Hagmar L., and Feychting M. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur. J. Cancer 42 (2006) 3028-3033
79. Strasser A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5 (2005) 189-200
80. Strasser A., Harris A.W., Huang D.C., Krammer P.H., and Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14 (1995) 6136-6147
81. Straus S.E., Jaffe E.S., Puck J.M., Dale J.K., Elkon K.B., Rosen-Wolff A., Peters A.M., Sneller M.C., Hallahan C.W., Wang J., et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98 (2001) 194-200
82. Suarez F., Lortholary O., Hermine O., and Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107 (2006) 3034-3044
83. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., Liang C., Bartov G., McDaniel L.D., Zhou X.J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103 (2006) 9970-9975
84. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., Yoshida R., Wakeham A., Higuchi T., Fukumoto M., et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14 (2001) 523-534
85. Tada Y., Nagasawa K., Ho A., Morito F., Koarada S., Ushiyama O., Suzuki N., Ohta A., and Mak T.W. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. J. Immunol. 163 (1999) 3153-3159
86. Tighe H., Heaphy P., Baird S., Weigle W.O., and Carson D.A. Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice. J. Exp. Med. 181 (1995) 599-606
87. Todd J.A., Bell J.I., and McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329 (1987) 599-604
88. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., Di Genova G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
89. Vyse T.J., and Todd J.A. Genetic analysis of autoimmune disease. Cell 85 (1996) 311-318
90. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770
91. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., and Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 301 (2003) 1374-1377
92. Williams L.M., and Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8 (2007) 277-284
93. Winandy S., Wu L., Wang J.H., and Georgopoulos K. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J. Exp. Med. 190 (1999) 1039-1048
94. Wong P., Barton G.M., Forbush K.A., and Rudensky A.Y. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J. Exp. Med. 193 (2001) 1179-1187
95. Wright A.F., Carothers A.D., and Pirastu M. Population choice in mapping genes for complex diseases. Nat. Genet. 23 (1999) 397-404
96. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
97. Yokoi N., Komeda K., Wang H.Y., Yano H., Kitada K., Saitoh Y., Seino Y., Yasuda K., Serikawa T., and Seino S. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat. Genet. 31 (2002) 391-394
98. Zerrahn J., Held W., and Raulet D.H. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88 (1997) 627-636
99. Zhang J.Q., Okumura C., McCarty T., Shin M.S., Mukhopadhyay P., Hori M., Torrey T.A., Naghashfar Z., Zhou J.X., Lee C.H., et al. Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl. J. Exp. Med. 200 (2004) 1467-1478
100. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., and Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 (2007) 936-940
101. Zintzaras E., Voulgarelis M., and Moutsopoulos H.M. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch. Intern. Med. 165 (2005) 2337-2344